The U.S. government plans to spend close to $2 billion in order to pay researchers and biotechnology companies to develop new drugs, vaccines and equipment to shorten the six- to nine-month time frame currently needed to make a flu vaccine.
U.S. health officials plan to persuade more Americans to get vaccinated against the flu this fall. The CDC is recommending flu vaccine for all Americans ages six months and older, except for people with egg allergies and some other conditions.
The Wall Street Journal reported:
“To meet anticipated demand, manufacturers are producing between 160 million and 165 million doses this year, more than ever before ... The CDC is accelerating development of two new tools to speed production of vaccine ...
One involves optimizing seed strains of virus used to make vaccine ... Another is a new method to determine the amount of antigen -- the ingredient that prompts an immune response -- in a vaccine vial.”